Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Jiangsheng Xu; Yunhua Liu; Yujing Li; Hai Wang; Samantha Stewart; Kevin Van der Jeught; Pranay Agarwal; Yuntian Zhang; Sheng Liu; Gang Zhao; Jun Wan; Xiongbin Lu; Xiaoming He

doi:10.1038/s41565-019-0417-y

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Nat Nanotechnol. 2019 May;14(5):496. doi: 10.1038/s41565-019-0417-y.

Authors

Jiangsheng Xu^{1

2

3}, Yunhua Liu^{4

5}, Yujing Li^{4

5}, Hai Wang^{1

2

3}, Samantha Stewart¹, Kevin Van der Jeught^{4

5}, Pranay Agarwal³, Yuntian Zhang^{1

6}, Sheng Liu⁴, Gang Zhao⁶, Jun Wan⁴, Xiongbin Lu^{7

8}, Xiaoming He^{9

10

11

12

13}

Affiliations

¹ Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
² Comprehensive Cancer Centre, The Ohio State University, Columbus, OH, USA.
³ Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA.
⁴ Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
⁵ Melvin and Bren Simon Cancer Centre, Indiana University School of Medicine, Indianapolis, IN, USA.
⁶ Department of Electronics Science and Technology, University of Science and Technology of China, Hefei, Anhui, China.
⁷ Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. xiolu@iu.edu.
⁸ Melvin and Bren Simon Cancer Centre, Indiana University School of Medicine, Indianapolis, IN, USA. xiolu@iu.edu.
⁹ Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA. shawnhe@umd.edu.
¹⁰ Comprehensive Cancer Centre, The Ohio State University, Columbus, OH, USA. shawnhe@umd.edu.
¹¹ Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA. shawnhe@umd.edu.
¹² Robert E. Fischell Institute for Biomedical Devices, University of Maryland, College Park, MD, USA. shawnhe@umd.edu.
¹³ Marlene and Stewart Greenebaum Comprehensive Cancer Centre, University of Maryland, Baltimore, MD, USA. shawnhe@umd.edu.

PMID: 30837690
DOI: 10.1038/s41565-019-0417-y

Abstract

The Supplementary Information originally published with this Article was an older version, in which 'IFN-γ' was misspelled 'INF-γ' in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.

Publication types

Published Erratum